Today: 11 June 2026
Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week
7 February 2026
2 mins read

Lucid stock jumps 14% as Dow tops 50,000 — what LCID investors watch next week

New York, Feb 7, 2026, 05:57 EST — The market is now closed.

  • Lucid Group shares rebounded Friday, ending the session at $10.86, a 14% gain after the steep decline seen the previous day.
  • That shift came as Wall Street staged a broad rebound, sending high-volatility names higher.
  • Attention shifts to Lucid’s Feb. 24 report, with investors eyeing cash levels, demand signals, and any updates on the 2026 forecast.

Lucid Group Inc surged almost 14% Friday, closing at $10.86 after dropping over 8% the previous session. Shares edged down roughly 0.1% in post-market action.

The rebound is notable—Lucid’s stock has turned into a high-volatility barometer for risk appetite lately. Friday’s jump followed a string of rough sessions for growth stocks. Now, with U.S. markets closed for the weekend, eyes turn to Monday to see if the move holds up when trading resumes.

Lucid offered no fresh company news on Friday, so the stock’s action spoke for itself. Investors looking for answers will have to wait for Lucid’s upcoming quarterly report this month, which should shed light on cash burn and demand—typically the key battlegrounds in debates over the stock.

Friday saw Wall Street push higher, the Dow finishing above 50,000 for the first time ever. The S&P 500 and Nasdaq closed up as well. Chip shares outperformed, driven by renewed bets on AI-focused capital spending. Big tech’s aggressive equipment and infrastructure outlays were in sharp focus after fresh announcements.

“The recent driver has really been the broadening out we’re seeing—beyond just tech and the AI trade,” said Chuck Carlson, chief executive officer at Horizon Investment Services. Reuters

Lucid’s upcoming update is crucial. According to an SEC filing, the company turned out 8,412 vehicles in Q4 2025, delivering 5,345 of those. For all of 2025, Lucid produced 18,378 vehicles and delivered 15,841. Deliveries here refer to cars actually handed to buyers.

EV demand hasn’t been consistent, particularly at the upper end of the market, following the end of the $7,500 U.S. federal tax credit in September, according to Reuters. Lucid is aiming to attract more buyers, rolling out its Gravity Touring SUV with prices starting at $79,900, Reuters noted. Both Tesla and Rivian have flagged headwinds for premium EVs, too.

Still, a weekend rebound leaves Lucid facing the same nagging issues: Can it really turn its production pace into consistent sales, and will pricing and incentives in the sector hold steady—or are they headed for another bout of margin pressure?

The University of Michigan’s latest survey put U.S. consumer sentiment at a six-month high in early February, but concerns about the job market and inflation tied to tariffs persisted. “We may have seen the trough in consumer sentiment… as long as the recent stock market selloff doesn’t continue,” said Oren Klachkin, financial markets economist at Nationwide. Reuters

That blend is crucial for Lucid traders. When rates hold steady and consumers feel upbeat, discretionary stocks like Lucid usually catch a bid—though they can get hit hard if sentiment flips. This week’s sharp two-day move is a clear case in point.

Lucid’s next big date lands Feb. 24: fourth-quarter numbers, out after the bell. Shareholders get their shot to send in and upvote questions for management beginning Feb. 10.

Stock Market Today

  • Sigma Healthcare's Valuation Reassessed After Recent Share Price Declines
    June 11, 2026, 4:09 PM EDT. Sigma Healthcare (ASX:SIG) shares have declined 7.6% over the past week and 15.5% over the past year but exhibit strong long-term gains with a 231.7% return over three years. The stock currently trades at A$2.69, slightly below Simply Wall St's discounted cash flow (DCF) valuation of A$2.81 per share, indicating it is roughly fairly valued with a 4.1% discount. Despite short-term price weakness, Sigma Healthcare scores 2 out of 6 on valuation metrics, suggesting mixed signals on undervaluation. Its free cash flow is projected to increase substantially through 2028, supporting the fair value estimate. Investors are balancing recent price softness with long-term fundamentals amid ongoing reassessments of risk and return in Australia's healthcare supply chain sector.

Latest articles

Coeur Mining Climbs as S&P MidCap 400 Inclusion Approaches, Silver Stocks Gain

Coeur Mining Climbs as S&P MidCap 400 Inclusion Approaches, Silver Stocks Gain

11 June 2026
Coeur Mining surged 5.2% to $16.205 on heavy volume as investors positioned ahead of its S&P MidCap 400 addition effective June 22, following recent acquisitions and a sector-wide rally in precious-metals stocks; the company’s market cap hit $16.76 billion, with index inclusion and recent financial results drawing institutional attention.
Trump Media drops Truth Social spin-off, DJT holders turn to $6 bln TAE merger

Trump Media drops Truth Social spin-off, DJT holders turn to $6 bln TAE merger

11 June 2026
Trump Media, TAE Technologies and Texas Ventures Acquisition III have scrapped plans to spin off Truth Social and other media assets, keeping them within Trump Media as it pursues a merger with TAE; DJT shares traded at $8.03 Thursday after falling over 38% this year, with the next key event being the merger filing process and SEC registration.
Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen
Previous Story

Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive
Next Story

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

Go toTop